P. acnes CAMP factor-associated inflammation in acne vulgaris: a potential vaccination strategy Sep. 28, 2018
Concert Pharmaceuticals amends protocol of phase IIa trial with CTP-543 in alopecia areata Sep. 27, 2018
Patient enrollment ongoing in phase II study of M-1095 in chronic plaque-type psoriasis Sep. 26, 2018
Phase II results presented for BMS-986165 in patients with moderate to severe psoriasis Sep. 19, 2018
Ilumetri receives approval in Europe for treatment of moderate to severe chronic plaque psoriasis Sep. 19, 2018
RSS